Exclusive Enteral Nutrition vs. Infliximab in Chinese CD Patients

Summary

prospectively compared Exclusive Enteral Nutrition with Infliximab in the clinical outcomes, mucosal healing, nutrition improvements, adverse effects and gastrointestinal microbiota changes on Chinese Children With active Crohn's Disease

Timeline

Start

2022-10-01

Primary completion

2024-09-30

Completion

2024-09-30

Drugs

Indications